| Unresectable Stage III NSCLC: Highlights From the Oncology Meeting in Chicago 2024 | 03/31/2025 | |
| Differentiating and Managing Pneumonitis in Unresectable Stage III NSCLC: Case Discussion | 04/01/2025 | |
| Optimizing Consolidative Immunotherapy in Unresectable Stage III NSCLC: Case Discussion | 03/31/2025 | |
| Immunotherapy Approaches in Unresectable Stage III NSCLC: What’s on the Horizon? | 03/30/2025 | |
| Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC | 03/31/2025 | |
| Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show? | 04/01/2025 | |
| Resolving Practice Barriers to Consolidative Immunotherapy in Stage III NSCLC | 03/31/2025 | |
| Advances in Immunotherapy for Unresectable Stage III NSCLC | | |
